Coronavirus disease 2019 (COVID-19) diagnosis is based on molecular detection of SARS-CoV-2 in respiratory samples such as nasal swab (NS). However, the evidence that NS in patients with pneumonia was sometimes negative raises the attention to collect other clinical specimens. SARS-CoV-2 was shown in 10.3% rectal swabs (RS), 7.7% plasma, 1% urine, and 0% feces from 143 NS-positive patients. Potential infection by fluids different from respiratory secretion is possible but unlikely.
Detection of the SARS-CoV-2 in different biologic specimens from positive patients with COVID-19, in Northern Italy
Novazzi F.;Cassaniti I.;Piralla A.;Di Sabatino A.;Baldanti F.;Brunetti E.;Di Matteo A.;Seminari E.;Maiocchi L.;Zuccaro V.;Pagnucco L.;Mariani B.;Ludovisi S.;Lissandrin R.;Zanaboni D.;Novati S.;Maserati R.;Orsolini P.;Vecchia M.;Asperges E.;Colaneri M.;Di Filippo A.;Sambo M.;Biscarini S.;Roda S.;Pieri T. C.;Gallazzi I.;Sachs M.;Perlini S.;Alfano C.;Bonzano M.;Briganti F.;Crescenzi G.;Falchi A. G.;Guglielmana B.;Martino I.;Pettenazza P.;Quaglia F.;Sabena A.;Salinaro F.;Speciale F.;Zunino I.;Secco G.;Cappa G.;Maisak I.;Chiodi B.;Sciarrini M.;Vezzoni G.;Scattaglia L.;Boscolo E.;Zattera C.;Tassi M. F.;Capozza V.;Vignaroli D.;Bazzini M.;Iotti G.;Mojoli F.;Belliato M.;Perotti L.;Mongodi S.;Licari A.;Campanini G.;Cavanna C.;Comolli G.;Mariani B.;Maserati R.;Parea M.;Rovida F.;Brunco V.;Casali G.;Capella L.;Dossena L.;Garbagnoli G.;Guerrizio A.;Maliardi V.;Piemontese P.;Corcione A.;Di Martino R.;Fiorina L.;Gallone A.;Giardina F.;Mercato A.;Ratano G.;Sciabica I. M.;Tallarita M.;Vecchio Nepita E.;Oliviero B.;Nicora C.;Petronella V.;Marena C.;Muzzi A.;Lago P.;Cutti S.;Novelli V.;Comandatore F.;Batisti Biffignandi G.;Gaiarsa S.;
2020-01-01
Abstract
Coronavirus disease 2019 (COVID-19) diagnosis is based on molecular detection of SARS-CoV-2 in respiratory samples such as nasal swab (NS). However, the evidence that NS in patients with pneumonia was sometimes negative raises the attention to collect other clinical specimens. SARS-CoV-2 was shown in 10.3% rectal swabs (RS), 7.7% plasma, 1% urine, and 0% feces from 143 NS-positive patients. Potential infection by fluids different from respiratory secretion is possible but unlikely.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
